Literature DB >> 18181329

Growth inhibition of breast cancer cell line MCF-7 by siRNA silencing of Wilms tumor 1 gene.

Ruxapon Navakanit1, Potchanapond Graidist, Wilairat Leeanansaksiri, Chavaboon Dechsukum.   

Abstract

BACKGROUND: RNA interference (RNAi) is sequence-specific inhibition of gene expression induced by double-stranded RNA.
OBJECTIVE: Define the role of Wilms tumor 1 gene (WT1) in breast cancer oncogenesis using RNAi. MATERIAL AND
METHOD: MCF-7 breast cancer cells, which express a high level of WT1, were transfected with synthetic small interfering RNA (siRNA) targeting WT1 (siRNA(WT1)) resulting in inhibition of WTI expression, as well as growth, in a dose- and time-dependent manner. RESULT: The minimum concentration of siRNA(WT1) for growth inhibition and WT1 silencing was 25 nM and 50 nM respectively. WT1 expression was completely abolished at 200 nM siRNA,.
CONCLUSION: These data suggest that WTI1is indispensable for the survival of breast cancer MCF-7 cell line.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18181329

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  6 in total

1.  Downregulation of the WT1 gene expression via TMPyP4 stabilization of promoter G-quadruplexes in leukemia cells.

Authors:  Saeedeh Ghazaey Zidanloo; Abasalt Hosseinzadeh Colagar; Hossein Ayatollahi; Jahan-Bakhsh Raoof
Journal:  Tumour Biol       Date:  2016-01-27

2.  Wilms' tumor 1 gene (WT1) is overexpressed and provides an oncogenic function in pediatric nephroblastomas harboring the wild-type WT1.

Authors:  Surasak Sangkhathat; Samornmas Kanngurn; Welawee Chaiyapan; Podchanaporn Gridist; Wanwisa Maneechay
Journal:  Oncol Lett       Date:  2010-07-01       Impact factor: 2.967

3.  Wilms' tumor gene 1 (WT1) silencing inhibits proliferation of malignant peripheral nerve sheath tumor sNF96.2 cell line.

Authors:  Rosalba Parenti; Venera Cardile; Adriana Carol Eleonora Graziano; Carmela Parenti; Assunta Venuti; Maria Paola Bertuccio; Debora Lo Furno; Gaetano Magro
Journal:  PLoS One       Date:  2014-12-04       Impact factor: 3.240

Review 4.  WT1: The Hinge Between Anemia Correction and Cancer Development in Chronic Kidney Disease.

Authors:  Wen-Chin Lee; Chien-Hua Chiu; Tian-Huei Chu; Yu-Shu Chien
Journal:  Front Cell Dev Biol       Date:  2022-04-06

5.  Allosteric regulation of serine protease HtrA2 through novel non-canonical substrate binding pocket.

Authors:  Pruthvi Raj Bejugam; Raja R Kuppili; Nitu Singh; Nikhil Gadewal; Lalith K Chaganti; G Madhavi Sastry; Kakoli Bose
Journal:  PLoS One       Date:  2013-02-14       Impact factor: 3.240

Review 6.  The role of WT1 in breast cancer: clinical implications, biological effects and molecular mechanism.

Authors:  Ye Zhang; Wen-Ting Yan; Ze-Yu Yang; Yan-Ling Li; Xuan-Ni Tan; Jun Jiang; Yi Zhang; Xiao-Wei Qi
Journal:  Int J Biol Sci       Date:  2020-02-24       Impact factor: 6.580

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.